Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Lu Li

1PUBLICATIONS
5CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 17, 2022
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.

Qianping Liang, Feifei Chu, Lei Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Qianping Liang

1 joint publications

Feifei Chu

1 joint publications

Lei Zhang

1 joint publications

Yuanyuan Jiang

1 joint publications

Huili Wu

Frequent Collaborators

1 joint publications

Qianping Liang

1 joint publications

Feifei Chu

1 joint publications

Lei Zhang

1 joint publications

Yuanyuan Jiang

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

1.0K
See more related videos

Top Related Videos

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
04:20

Knockdown of <em>FAM83A</em> to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on : Feb 09, 2024

1.0K
See more related videos